Clinical trial
Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
NCT02759029 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
- Lead sponsor
- Gangnam Severance Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2016
- Completion date
- February 28, 2018
- Enrollment
- 123 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection